Page last updated: 2024-08-26

cobalt and fingolimod hydrochloride

cobalt has been researched along with fingolimod hydrochloride in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ab Rahim, S; Abdul Hamid Hasani, N; Hanafi, NI; Md Noor, J; Mohamed, AS; Sheikh Abdul Kadir, SH; Siran, R	1

Other Studies

1 other study(ies) available for cobalt and fingolimod hydrochloride

Article	Year
Ursodeoxycholic acid protects cardiomyocytes against cobalt chloride induced hypoxia by regulating transcriptional mediator of cells stress hypoxia inducible factor 1α and p53 protein. Cell biochemistry and function, 2017, Volume: 35, Issue:7 Topics: Animals; Cell Hypoxia; Cell Proliferation; Cell Survival; Cells, Cultured; Cobalt; Fingolimod Hydrochloride; Gene Expression Regulation; Hypoxia-Inducible Factor 1, alpha Subunit; Myocytes, Cardiac; Pertussis Toxin; Protective Agents; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Signal Transduction; Tumor Suppressor Protein p53; Ursodeoxycholic Acid	2017

Article

Year

Ursodeoxycholic acid protects cardiomyocytes against cobalt chloride induced hypoxia by regulating transcriptional mediator of cells stress hypoxia inducible factor 1α and p53 protein.

Cell biochemistry and function, 2017, Volume: 35, Issue:7

Topics: Animals; Cell Hypoxia; Cell Proliferation; Cell Survival; Cells, Cultured; Cobalt; Fingolimod Hydrochloride; Gene Expression Regulation; Hypoxia-Inducible Factor 1, alpha Subunit; Myocytes, Cardiac; Pertussis Toxin; Protective Agents; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Signal Transduction; Tumor Suppressor Protein p53; Ursodeoxycholic Acid

2017